As on April 07, 2021, AstraZeneca PLC (NASDAQ: AZN) started slowly as it slid -1.63% to $48.42. During the day, the stock rose to $49.12 and sunk to $48.26 before settling in for the price of $49.22 at the close. Taking a more long-term approach, AZN posted a 52-week range of $42.84-$64.94.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 1.50%. Meanwhile, its Annual Earning per share during the time was 1.70%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 137.20%. This publicly-traded company’s shares outstanding now amounts to $2.62 billion, simultaneously with a float of $2.60 billion. The organization now has a market capitalization sitting at $127.77 billion. At the time of writing, stock’s 50-day Moving Average stood at $49.81, while the 200-day Moving Average is $52.91.
It is imperative to bring your focus towards the efficiency factor of the conglomerate that has a total of 76100 employees. It has generated 282,763 per worker during the last fiscal year. Meanwhile, its income per employee was 32,750. The stock had 5.35 Receivables turnover and 0.45 Total Asset turnover. For the Profitability, stocks gross margin was +74.01, operating margin was +16.98 and Pretax Margin of +14.29.
AstraZeneca PLC (AZN) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Drug Manufacturers – General industry. AstraZeneca PLC’s current insider ownership accounts for 0.50%, in contrast to 15.70% institutional ownership.
AstraZeneca PLC (AZN) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 12/30/2020, the company posted $0.53 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at $0.68) by -$0.15. This company achieved a net margin of +11.58 while generating a return on equity of 23.36. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
AstraZeneca PLC’s EPS increase for this current 12-month fiscal period is 137.20% and is forecasted to reach 3.27 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 19.50% through the next 5 years, which can be compared against the 1.70% growth it accomplished over the previous five years trading on the market.
AstraZeneca PLC (NASDAQ: AZN) Trading Performance Indicators
Let’s observe the current performance indicators for AstraZeneca PLC (AZN). It’s Quick Ratio in the last reported quarter now stands at 0.80. The Stock has managed to achieve an average true range (ATR) of 0.91. Alongside those numbers, its PE Ratio stands at $39.79, and its Beta score is 0.56. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.80. Similarly, its price to free cash flow for trailing twelve months is now 480.35.
In the same vein, AZN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 1.22, and analysts are predicting that it will be 3.27 at the market close of one year from today.
Technical Analysis of AstraZeneca PLC (AZN)
Through scrutinizing the latest numbers posted by the [AstraZeneca PLC, AZN], it can be observed that its last 5-days Average volume of 6.91 million was lower the volume of 11.0 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 19.73% While, its Average True Range was 0.86.
Raw Stochastic average of AstraZeneca PLC (AZN) in the period of the previous 100 days is set at 16.72%, which indicates a major rise in contrast to 5.42% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 28.37% that was higher than 26.16% volatility it exhibited in the past 100-days period.